Japan· JP-1124020F3044
ブロマゼパム
A bromazepam product containing ブロマゼパム, registered in Japan by サンド, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Bromazepam is registered in 13 of 19 countries.
Countries holding a registration under ATC N05BA08 (bromazepam), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 6 of them publish a price we can compare per daily dose
Bromazepam · ATC N05BA08
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of bromazepam costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.11 in France to $1.17 in Switzerland — a ×11 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Bromazepam · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.17
- FR France$0.11
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ブロマゼパム
- Manufacturer
- サンド
- Country
- Japan (JP)
- ATC code
- N05BA08
- ATC class
- Bromazepam
- Defined daily dose
- 10 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
49 interactions on record for bromazepam.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bromazepam · interactions on record
49 records
49 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under N05BA08
Bromazepam, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e7d7b897-3ba3-4ff4-a526-19aea515f41a GET /v1/drugs/e7d7b897-3ba3-4ff4-a526-19aea515f41a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "３ｍｇ１錠",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "1124020F3044",
"category": "内用薬",
"price_yen": 6.3,
"generic_name": "ブロマゼパム",
"product_name_jp": null,
"therapeutic_class": "1124",
"transitional_expiry": null
}See everything about bromazepam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.